Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.
about
The Role of PPARs in CancerProstacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1Metformin as a new anti-cancer drug in adrenocortical carcinomaHuman adrenocortical carcinoma cell lines.Emerging therapy for adrenocortical carcinoma.Current and emerging therapies for advanced adrenocortical carcinoma.Current and emerging therapeutic options in adrenocortical cancer treatment.The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).Adrenocortical tumorigenesis.Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome.To Live or to Die: Prosurvival Activity of PPARgamma in Cancers.Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.Thiazolidinediones as anti-cancer agents.Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonistsmRNA and microRNA expression patterns in adrenocortical cancer.Adrenocortical tumors and insulin resistance: What is the first step?Rosiglitazone inhibits adrenocortical cancer cell proliferation by interfering with the IGF-IR intracellular signaling.Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease.The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
P2860
Q21342955-A68BE59B-9839-42CB-8AEF-CA6EBCAAAF45Q24303556-8F1AEAAC-C573-492E-80A5-62F835C36D35Q28468634-F4FEB50E-6516-4CA7-BA5F-99AC30373A6EQ34216956-99146F41-4057-4517-B0B6-63872AAAA130Q35018399-5BA2A9B9-C6A4-4EDF-B128-289B7AC136EDQ35584305-60FC626D-66E5-4DE7-A1C3-90D30225772AQ36183873-CA865BD2-7A62-40B1-8368-6574EC4E594FQ36328530-D47222DB-41A3-45A7-9254-79DE86EA863CQ36694025-331E27A0-EF87-449D-B71B-04E2820BCA82Q36865817-F7E901CD-088E-4C92-9651-8901D17EFA95Q36867693-12A48283-A54C-4DAB-9888-EBB2FEDFBCBFQ36958256-9F881856-54C0-467D-89EB-79607FC2B5FAQ37010188-D1232B11-27DA-44B1-A710-7C8325F654D9Q37212309-674549EB-93E5-43E0-B27E-E1EBCB8AC849Q37945250-7D03A846-2D84-4032-A8F2-926E46C9A80DQ38659703-C3FE6F54-65D2-44CF-AAFC-F26F655F3061Q39955398-B87EEE7E-1BAE-491F-8A22-F171A58CC234Q40326178-02546D0B-B921-4F3A-A504-318E5F3FD3A0Q42419278-0DADA0E6-7113-4644-BA36-F977CE694A2CQ42830687-5D20A07B-3222-46BC-BA2B-3DCADD321944
P2860
Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... on and induce differentiation.
@en
type
label
Peroxisome proliferator-activa ...... on and induce differentiation.
@en
prefLabel
Peroxisome proliferator-activa ...... on and induce differentiation.
@en
P2093
P50
P356
P1476
Peroxisome proliferator-activa ...... on and induce differentiation.
@en
P2093
German and Austrian Adrenal Network
Igor Shapiro
Martin Fassnacht
Martin Reincke
P304
P356
10.1210/JC.2004-1267
P407
P577
2005-05-10T00:00:00Z